{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:33:35Z","timestamp":1789868015091,"version":"4.0.1"},"update-to":[{"DOI":"10.1002\/14651858.cd011444.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:00:00Z","timestamp":1542153600000}}],"reference-count":78,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011444.pub3","type":"journal-article","created":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T12:37:45Z","timestamp":1543322265000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Mefloquine for preventing malaria in pregnant women"],"prefix":"10.1002","volume":"2018","author":[{"given":"Raquel","family":"Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Hospital Cl\u00ednic - Universitat de Barcelona; ISGlobal; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Pons-Duran","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic - Universitat de Barcelona; ISGlobal; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireia","family":"Piqueras","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic - Universitat de Barcelona; ISGlobal; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"Aponte","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic - Universitat de Barcelona; ISGlobal; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiko O","family":"ter Kuile","sequence":"additional","affiliation":[{"name":"Liverpool School of Tropical Medicine; Department of Clinical Sciences; Pembroke Place Liverpool Merseyside UK L3 5QA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Men\u00e9ndez","sequence":"additional","affiliation":[{"name":"Hospital Cl\u00ednic - Universitat de Barcelona; ISGlobal; Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,11,14]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD011444.pub3-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1086\/605474","article-title":"Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine","volume":"200","author":"Briand","year":"2009","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/QAI.0000000000000058","article-title":"Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials","volume":"65","author":"Denoeud-Ndam","year":"2014","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/QAI.0000000000000058","article-title":"Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials","volume":"65","author":"Denoeud-Ndam","year":"2014","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"9","key":"10.1002\/14651858.CD011444.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"e1001735","DOI":"10.1371\/journal.pmed.1001733","article-title":"Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-negative women: a multicentre randomized controlled trial","volume":"11","author":"Gonz\u00e1lez","year":"2014","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"e1001964","DOI":"10.1371\/journal.pmed.1001964","article-title":"Mortality, morbidity, and developmental outcomes in infants born to women who received either mefloquine or sulfadoxine-pyrimethamine as intermittent preventive treatment of malaria in pregnancy: a cohort study","volume":"13","author":"Rup\u00e9rez","year":"2016","journal-title":"PLoS Medicine"},{"issue":"9","key":"10.1002\/14651858.CD011444.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"e1001735","DOI":"10.1371\/journal.pmed.1001735","article-title":"Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial","volume":"11","author":"Gonz\u00e1lez","year":"2014","journal-title":"PLoS Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011444.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/infdis\/169.3.595","article-title":"Mefloquine prophylaxis prevents malaria during pregnancy: a double- blind, placebo-controlled study","volume":"169","author":"Nosten","year":"1994","journal-title":"Journal of Infectious Diseases"},{"issue":"8814","key":"10.1002\/14651858.CD011444.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0140-6736(92)92403-3","article-title":"Mefloquine prophylaxis against malaria for female travellers of childbearing age","volume":"340","author":"Balocco","year":"1992","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4269\/ajtmh.14-0783","article-title":"Mefloquine versus sulfadoxine-pyrimethamine for intermittent preventive treatment in pregnancy: a joint analysis on efficacy and tolerability","volume":"93","author":"Briand","year":"2015","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/QAI.0b013e3182615a58","article-title":"Tolerability of mefloquine intermittent preventive treatment for malaria in HIV-infected pregnant women in Benin","volume":"61","author":"Denoeud-Ndam","year":"2012","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2125.1990.tb03746.x","article-title":"Mefloquine antimalarial prophylaxis in pregnancy:dose finding and pharmacokinetic study","volume":"30","author":"Nosten","year":"1990","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"3","key":"10.1002\/14651858.CD011444.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1708-8305.1998.tb00484.x","article-title":"Safety of mefloquine and other antimalarial agents in the first trimester of pregnancy","volume":"5","author":"Phillips-Howard","year":"1998","journal-title":"Journal of Travel Medicine"},{"issue":"11","key":"10.1002\/14651858.CD011444.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"e124","DOI":"10.1093\/cid\/cis215","article-title":"Pregnancy and fetal outcomes after exposure to mefloquine in the pre- and periconception period and during pregnancy","volume":"54","author":"Schlagenhauf","year":"2012","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD011444.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/517315","article-title":"The effects of inadvertent exposure of mefloquine chemoprophylaxis on pregnancy outcomes and infants of US Army servicewomen","volume":"176","author":"Smoak","year":"1992","journal-title":"Journal of Infectious Diseases"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011444.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4269\/ajtmh.1996.55.33","article-title":"The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011444.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.1996.55.17","article-title":"Comparability of treatment groups and risk factors for parasitemia at the first antenatal clinic visit in a study of malaria treatment and prevention in pregnancy in rural Malawi","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011444.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4269\/ajtmh.1996.55.2","article-title":"The problem of malaria and malaria control in pregnancy in sub-Saharan Africa","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011444.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4269\/ajtmh.1996.55.50","article-title":"Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011444.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.1996.55.24","article-title":"Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD011444.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4269\/ajtmh.1996.55.8","article-title":"Objectives and methodology in a study of malaria treatment and prevention in pregnancy in rural Malawi: the Mangochi Malaria Research Project","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4269\/ajtmh.1998.58.17","article-title":"Post-marketing surveillance of prophylactic mefloquine (Lariam) use in pregnancy","volume":"58","author":"Vanhauwere","year":"1998","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0022|cit22","unstructured":"A comparative study of mefloquine and SP as prophylaxis against malaria in pregnant HIV-infected patients Ongoing study September 2015"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pt.2013.12.007","article-title":"Malaria, primigravidae, and antibodies: knowledge gained and future perspectives","volume":"30","author":"Ata\u00edde","year":"2014","journal-title":"Trends in Parasitology"},{"issue":"7","key":"10.1002\/14651858.CD011444.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/j.1365-3156.2007.01859.x","article-title":"Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin","volume":"12","author":"Aubouy","year":"2007","journal-title":"Tropical Medicine & International Health"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/00002030-200303070-00014","article-title":"The effect of dual infection with HIV and malaria on pregnancy outcomes in western Kenya","volume":"17","author":"Ayisi","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1475-2875-7-27","article-title":"Clinical malaria in African pregnant women","volume":"7","author":"Bardaji","year":"2008","journal-title":"Malaria Journal"},{"issue":"12","key":"10.1002\/14651858.CD011444.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1517\/14656566.2012.703651","article-title":"Intermittent preventive treatment of malaria in pregnant women and infants: making best use of the available evidence","volume":"13","author":"Bardaji","year":"2012","journal-title":"Expert Opinion in Pharmacotherapy"},{"issue":"6","key":"10.1002\/14651858.CD011444.pub3-BIB0028|cit28","first-page":"1005","article-title":"An analysis of malaria in pregnancy in Africa","volume":"61","author":"Brabin","year":"1983","journal-title":"Bulletin of the World Health Organization"},{"issue":"6","key":"10.1002\/14651858.CD011444.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/605474","article-title":"Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine","volume":"200","author":"Briand","year":"2009","journal-title":"Journal of Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"e4551","DOI":"10.1371\/journal.pone.0004551","article-title":"Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment","volume":"4","author":"Carrara","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0031|cit31","unstructured":"Centers for Disease Control and Prevention Yellow Book - Malaria, Chapter 3. Travelers' Health Available from wwwnc.cdc.gov\/travel\/yellowbook\/2016\/infectious-diseases-related-to-travel\/malaria"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0032|cit32","unstructured":"Centers for Disease Control and Prevention CDC Malaria Maps Available from https:\/\/www.cdc.gov\/malaria\/travelers\/about_maps.html"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","article-title":"Epidemiology and burden of malaria in pregnancy","volume":"7","author":"Desai","year":"2007","journal-title":"Lancet Infectious Diseases"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0034|cit34","unstructured":"Desai M Hill J Fernandes S Walker P Pell C Gutman J Prevention of malaria in pregnancy Lancet Infect Diseases 10.1016\/S1473-3099(18)30064-1"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0035|cit35","unstructured":"US Food Drug Administration Lariam-brand of mefloquine hydrochloride. 2004 Available from www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/019591s024s025lbl.pdf"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003755.pub2","article-title":"Insecticide-reated nets for preventing malaria in pregnancy","author":"Gamble","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD011444.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1371\/journal.pmed.0040107","article-title":"Insecticide-treated nets for the prevention of malaria in pregnancy: a systematic review of randomised controlled trials","volume":"4","author":"Gamble","year":"2007","journal-title":"PLoS Medicine"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1586\/eri.11.167","article-title":"HIV and malaria interactions: where do we stand?","volume":"10","author":"Gonzalez","year":"2012","journal-title":"Expert Review of Anti-infective Therapy"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1475-2875-13-75","article-title":"Mefloquine safety and tolerability in pregnancy: a systematic literature review","volume":"13","author":"Gonzalez","year":"2014","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0040|cit40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1475-2875-13-75","article-title":"Mefloquine safety and tolerability in pregnancy: a systematic literature review","volume":"13","author":"Gonz\u00e1lez","year":"2014","journal-title":"Malaria Journal"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0041|cit41","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT www.gradeworkinggroup.org\/ 2015"},{"issue":"4","key":"10.1002\/14651858.CD011444.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1128\/CMR.17.4.760-769.2004","article-title":"Impact of malaria during pregnancy on low birth weight in sub-Saharan Africa","volume":"17","author":"Guyatt","year":"2004","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0043|cit43","unstructured":"Higgins JPT Altman DG Sterne JAC editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1475-2875-11-134","article-title":"Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya","volume":"11","author":"Iriemenam","year":"2012","journal-title":"Malaria Journal"},{"issue":"6","key":"10.1002\/14651858.CD011444.pub3-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"594\u2013604","DOI":"10.1001\/jama.2012.216231","article-title":"Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis","volume":"309","author":"Kayentao","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"e0168780","DOI":"10.1371\/journal.pone.0168780","article-title":"Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: a pooled analysis of 19,850 individual patients","volume":"12","author":"Lee","year":"2017","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1002\/14651858.CD011444.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"679","DOI":"10.4269\/ajtmh.2001.65.679","article-title":"Efficacy of mefloquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum infection in Machinga District, Malawi, 1998","volume":"65","author":"MacArthur","year":"2001","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1002\/14651858.CD011444.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"9438","DOI":"10.1371\/journal.pone.0009438","article-title":"Malaria prevention with IPTp during pregnancy reduces neonatal mortality","volume":"5","author":"Menendez","year":"2010","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1002\/14651858.CD011444.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"e1934","DOI":"10.1371\/journal.pone.0001934","article-title":"A randomized placebo-controlled trial of intermittent preventive treatment in pregnant women in the context of insecticide treated nets delivered through the antenatal clinic","volume":"3","author":"Men\u00e9ndez","year":"2008","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/cid\/ciq049","article-title":"HIV and placental infection modulate the appearance of drug-resistant Plasmodium falciparum in pregnant women who receive intermittent preventive treatment","volume":"52","author":"Men\u00e9ndez","year":"2011","journal-title":"Clinical Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD011444.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1086\/592455","article-title":"Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana","volume":"198","author":"Mockenhaupt","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD011444.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1086\/515183","article-title":"The effects of mefloquine treatment in pregnancy","volume":"28","author":"Nosten","year":"1999","journal-title":"Clinical Infectious Diseases"},{"issue":"9226","key":"10.1002\/14651858.CD011444.pub3-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0140-6736(00)02505-8","article-title":"Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study","volume":"356","author":"Nosten","year":"2000","journal-title":"Lancet"},{"issue":"8571","key":"10.1002\/14651858.CD011444.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/S0140-6736(87)91195-0","article-title":"Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum","volume":"2","author":"Oduola","year":"1987","journal-title":"Lancet"},{"issue":"10","key":"10.1002\/14651858.CD011444.pub3-BIB0055|cit55","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1508606","article-title":"Four artemisinin-based treatments in African pregnant women with malaria","volume":"374","author":"Pekyi","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD011444.pub3-BIB0056|cit56","first-page":"370","article-title":"CNS adverse events associated with antimalarial agents. Fact or fiction?","volume":"12","author":"Phillips-Howard","year":"1995","journal-title":"Drug Experience"},{"issue":"10","key":"10.1002\/14651858.CD011444.pub3-BIB0057|cit57","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000169.pub3","article-title":"Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment","author":"Radeva-Petrova","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0058|cit58","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1475-2875-9-357","article-title":"The position of mefloquine as a 21st century malaria chemoprophylaxis","volume":"9","author":"Schlagenhauf","year":"2010","journal-title":"Malaria Journal"},{"issue":"8","key":"10.1002\/14651858.CD011444.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1086\/591968","article-title":"Placental malaria increases malaria risk in the first 30 months of life","volume":"47","author":"Schwarz","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD011444.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1517\/14656561003733599","article-title":"Current knowledge and challenges of antimalarial drugs for treatment and prevention in pregnancy","volume":"11","author":"Sevene","year":"2010","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"8856","key":"10.1002\/14651858.CD011444.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0140-6736(93)90814-W","article-title":"Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa","volume":"341","author":"Steffen","year":"1993","journal-title":"Lancet"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD011444.pub3-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.1996.55.24","article-title":"Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi","volume":"55","author":"Steketee","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2001.64.28","article-title":"The burden of malaria in pregnancy in malaria-endemic areas","volume":"64","author":"Steketee","year":"2001","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1002\/14651858.CD011444.pub3-BIB0065|cit65","first-page":"631","article-title":"Mefloquine treatment of acute falciparummalaria: a prospective study of non-serious adverse effects in 3673 patients","volume":"73","author":"ter Kuile","year":"1995","journal-title":"Bulletin of the World Health Organization"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD011444.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4269\/ajtmh.2004.71.41","article-title":"The burden of co-infection with human immunodeficiency virus type 1 and malaria in pregnant women in sub-Saharan Africa","volume":"72","author":"ter Kuile","year":"2004","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"23","key":"10.1002\/14651858.CD011444.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1001\/jama.297.23.2603","article-title":"Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review","volume":"297","author":"ter Kuile","year":"2007","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4269\/ajtmh.2002.67.44","article-title":"Malaria and human immunodeficiency virus infection as risk factors for anemia in infants in Kisumu, western Kenya","volume":"67","author":"Eijk","year":"2002","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1002\/14651858.CD011444.pub3-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/00002030-200303070-00015","article-title":"HIV increases the risk of malaria in women of all gravidities in Kisumu, Kenya","volume":"17","author":"Eijk","year":"2003","journal-title":"AIDS"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/ncomms2605","article-title":"A model of parity-dependent immunity to placental malaria","volume":"4","author":"Walker","year":"2013","journal-title":"Nature Communications"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1371\/journal.pmed.0020003","article-title":"Intermittent presumptive treatment for malaria","volume":"2","author":"White","year":"2005","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0072|cit72","unstructured":"World Health Organization A strategic framework for malaria prevention and control during pregnancy in the African Region World Health Organization Regional Office for Africa 2004"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0073|cit73","unstructured":"World Health Organization World malaria report World Health Organization 2012"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0074|cit74","unstructured":"World Health Organization Intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP) Updated WHO Policy Recommendation October 2012"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0075|cit75","unstructured":"World Health Organization Policy brief for the implementation of intermittent preventive treatment of malaria in pregnancy using sulfadoxine-pyrimethamine (IPTp-SP). WHO\/HTM\/GMP\/2014.4 Available from www.who.int\/malaria\/publications\/atoz\/iptp-sp-updated-policy-brief-24jan2014.pdf?ua=1"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0076|cit76","unstructured":"World Health Organization Guidelines for the Treatment of Malaria, 3rd edition Available from www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/"},{"key":"10.1002\/14651858.CD011444.pub3-BIB0077|cit77","first-page":"346","article-title":"Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting","volume":"12","author":"World Health Organization. Malaria Policy Advisory Committee and Secretariat","year":"2013","journal-title":"Malaria Journal"},{"issue":"1","key":"10.1002\/14651858.CD011444.pub3-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011444","article-title":"Mefloquine for preventing malaria in pregnant women","author":"Gonz\u00e1lez","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD011444.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T21:31:39Z","timestamp":1750023099000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011444.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Infectious Diseases Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,11,14]]},"references-count":78,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011444.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,14]]}}}